1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Supporting Research Using the Resources from the Osteoarthritis Initiative (OAI) is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). This funding opportunity invites research grant applications focused on utilizing the Osteoarthritis Initiative (OAI) database, clinical data, and images.
Research topics of interest include the use of biospecimens to discover biochemical markers for early or progressive disease, and the investigation of MRI features as predictors of radiographic or clinical OA outcomes. It also encourages the development of robust, reproducible tools for automated image analysis (MRI, X-ray) for OA diagnosis and monitoring.
Get alerted about grants like this
Get emailed when new opportunities from “National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Supporting Research Using the Resources from the Osteoarthritis Initiative (OAI) | Grants & Funding U.S. Department of Health and Human Services National Institutes of Health Supporting Research Using the Resources from the Osteoarthritis Initiative (OAI) When beginning your next investigator-initiated application, consider the following NIH highlighted topic.
The area of science described below is of interest to the listed NIH Institutes, Centers, and Offices (ICOs). This is not a notice of funding opportunity (NOFO). Apply through an appropriate NIH Parent Funding Announcement or another broad NIH opportunity available on Grants.
gov . Learn how to interpret and use Highlighted Topics . Post Date: January 26, 2026 Expiration Date: January 26, 2028 We invite research grant applications focused on the use of the Osteoarthritis Initiative (OAI) database, clinical data, and images.
We aim to expand the use of these resources by investigators in the broader research community. While the OAI resource has been extensively used by OA investigators, significant opportunities remain for novel analyses of the data, exploration of OA epidemiology and progression, and application of new technologies to biospecimens and genetic data.
The OAI also serves as a valuable training resource and can foster interdisciplinary collaborations beyond musculoskeletal researchers. Examples of possible topics include, but are not limited to: Identification and validation of modifiable and non-modifiable risk factors for knee and hip OA. Use of biospecimens to discover biochemical markers for early or progressive disease.
Integration of biospecimens with imaging and clinical data to improve patient phenotyping. Predictive modeling of intervention effectiveness (bio-behavioral, pharmacologic, etc.) based on existing OAI data. Investigation of MRI features as predictors of radiographic or clinical OA outcomes.
Development of robust, reproducible tools for automated image analysis (MRI, X-ray) for OA diagnosis and monitoring. Studies on disease trajectory and structural changes (e.g., muscles, ligaments, bone) to identify whole joint treatment strategies. Ancillary studies extending OAI follow-up to assess long-term consequences of OA and its links to other musculoskeletal disorders.
Combined analyses using OAI and other compatible cohorts to study broader OA-related disability questions. Other cohorts to be considered include but are not limited to: Multicenter Osteoarthritis Study (MOST): https://most. ucsf.
edu/ The National Institute of Aging (NIA) Health, Aging, and Body Composition (Health ABC) cohort The NIH Baltimore Longitudinal Study of Aging (BLSA) Cohort Application of AI, deep learning, and advanced data science to enhance data integration and clinical interpretation. Development of complex, multimodal predictive models that outperform single-domain predictions.
Use of real-world data (e.g., EHRs) to evaluate treatment response, adverse outcomes, and reduce health disparities in OA care. Central Scientific Contact: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) NIAMS has interest in novel analyses of the OAI data, exploration of OA epidemiology and progression, and application of new technologies to biospecimens and genetic data.
The OAI also serves as a valuable training resource and can foster interdisciplinary collaborations that include musculoskeletal researchers. IC may give special consideration to support meritorious applications in this topic area.
National Institute on Aging (NIA) Office of Research on Women's Health (ORWH) Osteoarthritis (OA) is more common and often more severe in women, with distinct patterns of presentation stemming from an interplay of hormonal, genetic, anatomical, and lifestyle factors.
The Office of Research on Women's Health (ORWH) is interested in the following OA-related research: Leveraging Osteoarthritis Initiative (OAI), artificial intelligence/machine learning (AI/ML), and other emerging technologies to address osteoarthritis risk and resilience factors in women and elucidate the sex- linked underlying mechanisms that preserve musculoskeletal/ bone health across the life course, especially during menopause.
Developing novel and innovative diagnostic tools and interventions to prevent OA in women. Discovering new therapies aimed at halting osteoarthritis progression and reducing disability in women. This office does not award grants.
Applications must be relevant to the objectives of at least one of the participating NIH Institutes and Centers listed in this topic. Elena Gorodetsky, M. D.
, Ph. D. For technical issues E-mail OER Webmaster
According to the current listing, eligibility includes: Investigators in the broader research community, including musculoskeletal researchers. The OAI also serves as a valuable training resource and can foster interdisciplinary collaborations. Universities are eligible. Confirm the full requirements in the official notice before applying.
Applications for Supporting Research Using the Resources from the Osteoarthritis Initiative (OAI) are due January 26, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Supporting Research Using the Resources from the Osteoarthritis Initiative (OAI) is funded by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Leveraging and Accelerating the Progress Achieved in the Restoring Joint Health and Function to Reduce Pain (RE-JOIN) Consortium (Forecast) is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). This forecasted NOFO aims to expand upon the achievements of the Restoring Joint Health and Function to Reduce Pain (RE-JOIN) Consortium, a part of the NIH Helping to End Addiction Long Term (HEAL) initiative.
Advancing Research into the Cause and Treatment of Rare Skin Diseases is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Center for Advancing Translational Sciences (NCATS), National Institute of Environmental Health Sciences (NIEHS) (NIH). This NIH highlighted topic aims to facilitate research on rare skin diseases, with a focus on projects involving multidisciplinary teams of basic, translational, and clinical scientists.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.